These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 27877020

  • 21. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP, Kushwah V, Katiyar SS, Kumar P, Pillay V, Suresh S, Jain S.
    Int J Pharm; 2017 Dec 20; 534(1-2):1-13. PubMed ID: 28970115
    [Abstract] [Full Text] [Related]

  • 22. 20(S)-25-methoxyl-dammarane-3β,12β,20-triol attenuates endoplasmic reticulum stress via ERK/MAPK signaling pathway.
    Qin H, Li W, Sun Y, Bao Y, Sun L, Song Z, Zheng L, Zhao Y, Li Y.
    Eur J Pharmacol; 2018 Oct 05; 836():75-82. PubMed ID: 30096296
    [Abstract] [Full Text] [Related]

  • 23. Enhanced oral bioavailability of salvianolic acid B by phospholipid complex loaded nanoparticles.
    Peng Q, Gong T, Zuo J, Liu J, Zhao D, Zhang Z.
    Pharmazie; 2008 Sep 05; 63(9):661-6. PubMed ID: 18819519
    [Abstract] [Full Text] [Related]

  • 24. Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations.
    Zhao X, Shi C, Zhou X, Lin T, Gong Y, Yin M, Fan L, Wang W, Fang J.
    Eur J Pharm Sci; 2019 Oct 01; 138():104994. PubMed ID: 31302210
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo.
    Yue PF, Yuan HL, Xie H, Xiao XH, Yang M, Liao MX, Zhu WF, Cai PL.
    Drug Dev Ind Pharm; 2008 Jul 01; 34(7):708-18. PubMed ID: 18612911
    [Abstract] [Full Text] [Related]

  • 31. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
    Wang W, Wang H, Rayburn ER, Zhao Y, Hill DL, Zhang R.
    Br J Cancer; 2008 Feb 26; 98(4):792-802. PubMed ID: 18253123
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Natural Product Ginsenoside 20(S)-25-Methoxyl-Dammarane-3β, 12β, 20-Triol in Cancer Treatment: A Review of the Pharmacological Mechanisms and Pharmacokinetics.
    Kim D, Park M, Haleem I, Lee Y, Koo J, Na YC, Song G, Lee J.
    Front Pharmacol; 2020 Feb 26; 11():521. PubMed ID: 32425780
    [Abstract] [Full Text] [Related]

  • 34. Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability.
    Tan Q, Liu S, Chen X, Wu M, Wang H, Yin H, He D, Xiong H, Zhang J.
    AAPS PharmSciTech; 2012 Jun 26; 13(2):534-47. PubMed ID: 22454136
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex.
    Yue PF, Yuan HL, Li XY, Yang M, Zhu WF.
    Int J Pharm; 2010 Mar 15; 387(1-2):139-46. PubMed ID: 20005937
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H.
    Int J Pharm; 2014 Apr 25; 465(1-2):306-16. PubMed ID: 24456672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.